John M Climaco insider trades: CNS Pharmaceuticals (CNSP) stock purchases
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where John reports to the SEC
and 2 more companies
Open-market buys and sales
6 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Feb 1, 2024 | CNSP | ↑ Buy | 166,666 | $0.30 | $50K | Direct | Feb 6, 2024 (5d) |
| Aug 16, 2023 | CNSP | ↑ Buy | 2,750 | $1.80 | $5K | Direct | Aug 16, 2023 (0d) |
| Apr 12, 2023 | CNSP | ↑ Buy | 15,000 | $0.69 | $10K | Direct | Apr 14, 2023 (2d) |
| Mar 15, 2019 | DRAD | ↑ Buy | 6,000 | $0.82 | $5K | Direct | Mar 18, 2019 (3d) |
| Nov 13, 2013 | DRAD | ↑ Buy | 9,369 | $4.28 | $40K | Direct | Nov 14, 2013 (1d) |
| Aug 26, 2013 | DRAD | ↑ Buy | 3,731 | $2.67 | $10K | Direct | Oct 3, 2013 (38d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other CNSP insiders
Open-market trades in the last 12 months
About John M Climaco's insider trades
John M Climaco is Chief Executive Officer at CNS Pharmaceuticals (CNSP). Since Aug 26, 2013, John has reported 6 open-market purchases worth $120K and no sales on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include grants and awards (39 filings), option exercises (5 filings), shares returned to the company (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every CNSP insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.